The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats

British Journal of Pharmacology

Volumn 164, Issue 2, 2011, Pages 278-293

  Lima Garcia, J F ^a   Dutra, R C ^a   Da Silva, K A B S ^a   Motta, E M ^a   Campos, M M ^b   Calixto, J B ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

17(R)HDoHE; arthritis; AT RvD1; inflammatory pain; RvD series precursor

Indexed keywords

17 HYDROXY 4,7,10,13,15,17,19 DOCOSAHEXAENOIC ACID; ANTIINFLAMMATORY AGENT; ASPIRIN TRIGGERED RESOLVIN D1; CYCLOOXYGENASE 2; DEXAMETHASONE; FATTY ACID DERIVATIVE; GABAPENTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOMETACIN; INTERLEUKIN 1BETA; MORPHINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; HYPERALGESIA; JOINT STIFFNESS; MECHANICAL STIMULATION; NONHUMAN; PAIN; PAW EDEMA; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; SPINAL CORD; SPINAL GANGLION; SYSTEMIC THERAPY; THERMAL STIMULATION;

ANIMALS; ARTHRITIS; CHRONIC DISEASE; DOCOSAHEXAENOIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; FREUND'S ADJUVANT; HOT TEMPERATURE; INFLAMMATION; MALE; PAIN; RATS;

EID: 80051953486     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01345.x     Document Type: Article

References (69)

1. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, et al,. (2002). Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 346: 1113-1118. (Pubitemid 34984601)
2. Alexander SPH, Mathie A, Peters JA, (2009). Guide to receptors and channels (GRAC), 4th edition. Br J Pharmacol 150 (Suppl. 1): S1-S254.
3. Amaya F, Samad TA, Barrett L, Broom DC, Woolf CJ, (2009). Periganglionic inflammation elicits a distally radiating pain hypersensitivity by promoting COX-2 induction in the dorsal root ganglion. Pain 142: 59-67.
4. Bang S, Yoo S, Yang TJ, Cho H, Kim YG, Hwang SW, (2010). Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception. Br J Pharmacol 161: 707-720.
5. Bannenberg GL, Chiang N, Ariel A, Arita M, Tjonahen E, Gotlinger KH, et al,. (2005). Molecular circuits of resolution: formation and actions of resolvins and protectins. J Immunol 174: 4345-4355. (Pubitemid 40396017)
6. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M, (1996). Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 334: 1557-1560. (Pubitemid 26177482)
7. Bendele AM, (2001). Animal models of rheumatoid arthritis. J Musculoskelet Neuronal Interact 1: 377-385.
8. Binshtok AM, Wang H, Zimmermann K, Amaya F, Vardeh D, Shi L, et al,. (2008). Nociceptors are interleukin-1β sensors. J Neurosci 28: 14062-14073.
9. Brennan FM, McInnes IB, (2008). Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 118: 3537-3545.
10. Campbell EL, Louis NA, Tomassetti SE, Canny GO, Arita M, Serhan CN, et al,. (2007). Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution. FASEB J 21: 3162-3170. (Pubitemid 47565535)
11. Chan C-F, Sun W-Z, Lin J-K, Lin-Shiau S-Y, (2000). Activation of transcription factors of nuclear factor kappa B, activator protein-1 and octamer factors in hyperalgesia. Eur J Pharmacol 402: 61-68. (Pubitemid 30625311)
12. Coderre TJ, (2009). Spinal cord mechanisms of hyperalgesia and allodynia. In:, Basbaum AI, Bushnell MC, (eds). Science of Pain. Academic Press: San Diego, pp. 339-380.
13. Cortes-Burgos LA, Zweifel BS, Settle SL, Pufahl RA, Anderson GD, Hardy MM, et al,. (2009). CJ-13610, an orally active inhibitor of 5-lipoxygenase is efficacious in preclinical models of pain. Eur J Pharmacol 617: 59-67.
14. Croci T, Zarini E, (2007). Effect of the cannabinoid CB1 receptor antagonist rimonabant on nociceptive responses and adjuvant-induced arthritis in obese and lean rats. Br J Pharmacol 150: 559-566. (Pubitemid 46355562)
15. Dornelles FN, Santos DS, Van Dyke TE, Calixto JB, Batista EL Jr, Campos MM, (2009). In vivo up-regulation of kinin B1 receptors after treatment with Porphyromonas gingivalis lipopolysaccharide in rat paw. J Pharmacol Exp Ther 330: 756-763.
16. Duffield JS, Hong S, Vaidya VS, Lu Y, Fredman G, Serhan CN, et al,. (2006). Resolvin D series and protectin D1 mitigate acute kidney injury. J Immunol 177: 5902-5911. (Pubitemid 44628803)
17. Filep JG, (2009). Lipid mediator interplay: resolvin D1 attenuates inflammation evoked by glutathione-conjugated lipid peroxidation products. Br J Pharmacol 158: 1059-1061.
18. Firestein GS, (2003). Evolving concepts of rheumatoid arthritis. Nature 423: 356-361. (Pubitemid 40852711)
19. Gilroy DW, Lawrence T, Perretti M, Rossi AG, (2004). Inflammatory resolution: new opportunities for drug discovery. Nat Rev Drug Discov 3: 401-415.
20. GISSI-Prevenzione Investigators (1999). Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 354: 447-455.
21. González ELM, Patrignani P, Tacconelli S, Rodríguez LAG, (2010). Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding. Arthritis Rheum 62: 1592-1601.
22. Hargreaves K, Dubner R, Brown F, Flores C, Joris J, (1988). A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32: 77-88.
23. Hay CH, Trevethick MA, Wheeldon A, Bowers JS, De Belleroche JS, (1997). The potential role of spinal cord cyclooxygenase-2 in the development of Freund's complete adjuvant-induced changes in hyperalgesia and allodynia. Neurosci 78: 843-850. (Pubitemid 27179663)
24. Hegen M, Keith JC Jr, Collins M, Nickerson-Nutter CL, (2008). Utility of animal models for identification of potential therapeutics for rheumatoid arthritis. Ann Rheum Dis 67: 1505-1515.
25. Hong S, Gronert K, Devchand PR, Moussignac R-L, Serhan CN, (2003). Novel docosatrienes and 17S-Resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J Biol Chem 278: 14677-14687. (Pubitemid 36799790)
26. 2 causes nociceptive behaviour and mechanical allodynia: the role of prostanoid E receptors and protein kinases. Br J Pharmacol 150: 727-737. (Pubitemid 46440219)
27. Kasuga K, Yang R, Porter TF, Agrawal N, Petasis NA, Irimia D, et al,. (2008). Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution. J Immunol 181: 8677-8687.
28. Lawrence T, Willoughby DA, Gilroy DW, (2002). Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol 2: 787-795. (Pubitemid 37328718)
29. Lee K-M, Kang B-S, Lee H-L, Son S-J, Hwang S-H, Kim D-S, et al,. (2004). Spinal NF-κB activation induces COX-2 upregulation and contributes to inflammatory pain hypersensitivity. Eur J Neurosci 19: 3375-3381. (Pubitemid 38859555)
30. Leeb BF, Sautner J, Andel I, Rintelen B, (2006). Intravenous application of omega-3 fatty acids in patients with active rheumatoid arthritis. The ORA-1 Trial. An open pilot study. Lipids 41: 29-34.
31. Leem JW, Hwang JH, Hwang SJ, Park H, Kimb MK, Choib Y, (2001). The role of peripheral N-methyl-d-aspartate receptors in Freund's complete adjuvant induced mechanical hyperalgesia in rats. Neurosci Lett 297: 155-158. (Pubitemid 32011297)
32. Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN, (2001). Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol 2: 612-619. (Pubitemid 32677628)
33. McDougall JJ, Zhang C, Cellars L, Joubert E, Dixon CM, Vergnolle N, (2009). Triggering of proteinase-activated receptor 4 leads to joint pain and inflammation in mice. Arthritis Rheum 60: 728-737.
34. Manjavachi MN, Quintão NL, Campos MM, Deschamps IK, Yunes RA, Nunes RJ, et al,. (2010). The effects of the selective and non-peptide CXCR2 receptor antagonist SB225002 on acute and long-lasting models of nociception in mice. Eur J Pain 14: 23-31.
35. Montecucco C, Cavagna L, Caporali R, (2009). Pain and rheumatology: an overview of the problem. Eur J Pain 3 (Suppl.): 105-109.
36. Müller-Ladner U, Pap T, Gay RE, Neidhart M, Gay S, (2005). Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis. Nat Clin Pract Rheumatol 1: 102-110.
37. Nagakura Y, Okada M, Kohara A, Kiso T, Toya T, Iwai A, et al,. (2003). Allodynia and hyperalgesia in adjuvant-induced arthritic rats: time course of progression and efficacy of analgesics. J Pharmacol Exp Ther 306: 490-497. (Pubitemid 36886145)
38. Narita M, Shimamura M, Imai S, Kubota C, Yajima Y, Takagi T, et al,. (2008). Role of interleukin-1β and tumor necrosis factor-α dependent expression of cyclooxygenase-2 mRNA in thermal hyperalgesia induced by chronic inflammation in mice. Neurosci 152: 477-486.
39. Ossipov MH, Bian D, Malan TP Jr, Lai J, Porreca F, (1999). Lack of involvement of capsaicin-sensitive primary afferents in nerve-ligation injury induced tactile allodynia in rats. Pain 79: 127-133. (Pubitemid 29076747)
40. Pinto LA, Cunha TM, Vieira SM, Lemos HP, Verri WA Jr, Cunha FQ, et al,. (2010). IL-17 mediates articular hypernociception in antigen-induced arthritis in mice. Pain 148: 247-256.
41. Quan LD, Thiele GM, Tian J, Wang D, (2008). The development of novel therapies for rheumatoid arthritis. Expert Opin Ther Pat 18: 723-738.
42. Rossi A, Kapahi P, Natoli G, Takahashi T, Chen Y, Karin M, et al,. (2000). Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkB kinase. Nature 403: 103-108. (Pubitemid 30038530)
43. Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S, et al,. (2001). Interleukin-1β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410: 471-475. (Pubitemid 32240046)
44. Schaible HG, Grubb BD, (1993). Afferent and spinal mechanisms of joint pain. Pain 55: 5-54. (Pubitemid 23300815)
45. Schaible HG, Ebersberger A, Von Banchet GS, (2002). Mechanisms of pain in arthritis. Ann N Y Acad Sci 966: 343-354. (Pubitemid 34729193)
46. Schaible HG, Schmelz M, Tegeder I, (2006). Pathophysiology and treatment of pain in joint disease. Adv Drug Deliv Rev 58: 323-342. (Pubitemid 44294525)
47. Schaible HG, Richter F, Ebersberger A, Boettger MK, Vanegas H, Natura G, et al,. (2009). Joint pain. Exp Brain Res 196: 153-162.
48. Serhan CN, (2004). U.S. Patent No. 2004/0116408 A1.
49. Serhan CN, (2007). Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 25: 101-137. (Pubitemid 46697904)
50. Serhan CN, (2009). Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators. J Thromb Haemost 7: 44-48.
51. Serhan CN, Clish CB, (2003). U.S. Patent No. 6,670,396 B2.
52. Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Gronert K, (2000). Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal anti-inflammatory drugs and transcellular processing. J Exp Med 192: 1197-1204.
53. Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, et al,. (2002). Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 196: 1025-1037. (Pubitemid 35231761)
54. Serhan CN, Yacoubian S, Yang R, (2008). Anti-inflammatory and proresolving lipid mediators. Annu Rev Pathol Mech Dis 3: 279-312. (Pubitemid 351488283)
55. Serhan CN, Yang R, Martinoid K, Kassuga K, Pillai PM, Porter TF, et al,. (2009). Maresins: novel macrophage mediators with potent anti-inflammatory and proresolving actions. J Exp Med 206: 15-23.
56. Shir Y, Seltzer Z, (1990). A-fibers mediate mechanical hyperesthesia and allodynia and C-fibers mediate thermal hyperalgesia in a new model of causalgiform pain disorders in rats. Neurosci Lett 115: 62-67. (Pubitemid 20231593)
57. Sommer C, Birklein F, (2010). Fighting off pain with resolvins. Nature Med 16: 518-520.
58. Spite M, Summers L, Porter TF, Srivastava S, Bhatnagar A, Serhan CN, (2009). Resolvin D1 controls inflammation initiated by glutathione-lipid conjugates formed during oxidative stress. Br J Pharmacol 158: 1062-1073.
59. Stein C, Millan MJ, Herz A, (1988). Unilateral inflammation of the hindpaw in rats as a model of prolonged noxious stimulation: alterations in behavior and nociceptive thresholds. Pharmacol Biochem Behav 2: 451-455.
60. Straus DS, Pascual G, Li M, Welch JS, Ricote M, Hsiang C-H, et al,. (2000). 15-Deoxy-D12,14-prostaglandin J2 inhibits multiple steps in the NF-kB signaling pathway. Proc Natl Acad Sci U S A 97: 4844-4849. (Pubitemid 30238645)
61. Sun YP, Oh SF, Uddin J, Yang R, Gotlinger K, Campbell E, et al,. (2007). Resolvin D1 and its aspirin-triggered 17R epimer: stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J Biol Chem 282: 9323-9334. (Pubitemid 47104612)
62. Svensson CI, Zattoni M, Serhan CN, (2007). Lipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processing. J Exp Med 204: 245-252. (Pubitemid 46294540)
63. Uçeyler N, Schäfers M, Sommer C, (2009). Mode of action of cytokines on nociceptive neurons. Exp Brain Res 196: 67-78.
64. Vitor CE, Figueiredo CP, Hara DB, Bento AF, Mazzuco TL, Calixto JB, (2009). Therapeutic action and underlying mechanisms of a combination of two pentacyclic triterpenes, alpha- and beta-amyrin, in a mouse model of colitis. Br J Pharmacol 157: 1034-1044.
65. van Vollenhoven RF, (2009). Treatment of rheumatoid arthritis: state of the art. Nat Rev Rheumatol 5: 531-534.
66. Wegert S, Ossipov MH, Nichols ML, Bian D, Vanderah TW, Malan TP, et al,. (1997). Differential activities of intrathecal MK-801 or morphine to alter responses to thermal and mechanical stimuli in normal or nerve-injured rats. Pain 71: 57-64. (Pubitemid 27245231)
67. Xu X-J, Farkas-Szallasi T, Lundberg JM, Hiikfelt T, Wiesenfeld-Hallin Z, Szallasi A, (1997). Effects of the capsaicin analogue resiniferatoxin on spinal notice mechanisms in the rat: behavioral, electrophysiological and in situ hybridization studies. Brain Res 752: 52-60. (Pubitemid 27143897)
68. Xu ZZ, Zhang L, Liu T, Park JY, Berta T, Yang R, et al,. (2010). Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nature Med 16: 592-597.
69. Yacoubian S, Serhan CN, (2007). New endogenous anti-inflammatory and proresolving lipid mediators: implication for rheumatic diseases. Nat Clin Pract Rheumatol 3: 570-579. (Pubitemid 47506014)